Showing results 7 to 8 of 8
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 | ||
The addition of pretreatment plasma Epstein–Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification Journal:International Journal of Cancer | 2019 |